Effect of Paroxetine on COAT-Platelet Production in Normal Volunteers and Patients With Cardiovascular Disease
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00229528|
Recruitment Status : Completed
First Posted : September 29, 2005
Last Update Posted : September 22, 2008
|Condition or disease||Intervention/treatment||Phase|
|Coronary Artery Disease||Drug: Paxil-CR||Phase 4|
|Study Type :||Interventional (Clinical Trial)|
|Enrollment :||25 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Dose Ranging Study of the Effect of Paroxetine on COAT-Platelet Production in Normal Volunteers and Patients With Cardiovascular Disease|
|Study Start Date :||March 2004|
|Actual Primary Completion Date :||May 2006|
|Actual Study Completion Date :||May 2006|
- To define the percent COAT-platelet and response to Paxil-CR in 5 control subjects.
- To define the percent COAT-platelet and response to Paxil-CR in 20 patients with Coronary Artery Disease.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00229528
|United States, Oklahoma|
|The University of Oklahoma Health Sciences Center|
|Oklahoma City, Oklahoma, United States, 73190|
|Principal Investigator:||Stephen F. Hamilton, Pharm.D.||The University of Oklahoma College of Pharmacy|